Status:
RECRUITING
Bioimpedance Integration for Optimized Fluid Management in Decompensated Heart Failure
Lead Sponsor:
Mid and South Essex NHS Foundation Trust
Collaborating Sponsors:
Anglia Ruskin University
Conditions:
Heart Failure
Decompensated Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to test whether using Bioimpedance Analysis (BIA) can help manage fluid levels in patients with heart failure who are admitted to the hospital with worsening symptom...
Detailed Description
SCIENTIFIC RATIONALE Heart failure (HF) is a global health challenge affecting over 64 million people, with rising prevalence. Managing HF effectively is crucial to improving outcomes, but assessing a...
Eligibility Criteria
Inclusion
- Age \>18 years
- Patients with hospitalised with a decompensated episode of Heart Failure regardless of Ejection Fraction
- Able and willing to consent.
Exclusion
- Patients on a palliative care pathway and/or estimated life expectancy \<3 months
- Patients admitted to ITU/ on intensive care support.
- Patients currently taking part in any trials investigating new heart failure drug or interventional treatment.
- Patients requiring Renal Replacement Therapy.
- Patients unable or unwilling to give consent.
Key Trial Info
Start Date :
December 30 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
255 Patients enrolled
Trial Details
Trial ID
NCT07173426
Start Date
December 30 2024
End Date
December 1 2026
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Basildon University Hospital
Basildon, Essex, United Kingdom, SS16 5NL